Cambridge Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$250K Hold
3,647
0.01% 250
2023
Q4
$211K Buy
3,647
+467
+15% +$24.9K 0.01% 259
2023
Q3
$168K Buy
3,180
+33
+1% +$1.73K 0.01% 280
2023
Q2
$170K Hold
3,147
0.01% 286
2023
Q1
$157K Hold
3,147
0.01% 299
2022
Q4
$146K Sell
3,147
-19
-0.6% -$823 0.01% 316
2022
Q3
$123K Sell
3,166
-410
-11% -$16.4K 0.01% 333
2022
Q2
$133K Sell
3,576
-992
-22% -$40.4K 0.01% 355
2022
Q1
$202K Sell
4,568
-344
-7% -$14.9K 0.01% 337
2021
Q4
$208K Buy
+4,912
New +$206K 0.01% 326

Other funds holding BSX

Cambridge Trust's BSX Position: Q1 2024 in Review

Cambridge Trust held its Boston Scientific (BSX) position steady in Q1 2024 at 3,647 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #250.

Cambridge Trust first reported a position in BSX in Q4 2021 and has held it in 10 quarters since. 1,224 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Cambridge Trust held 3,647 shares of Boston Scientific worth $250K as of Q1 2024.
  • Cambridge Trust left its Boston Scientific share count unchanged in Q1 2024.
  • Boston Scientific made up 0.01% of Cambridge Trust's portfolio in Q1 2024, its #250 holding.
  • Cambridge Trust first reported a position in Boston Scientific in Q4 2021 and has held it in 10 quarters since.
  • 1,224 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.